Bridge Therapeutics

Bridge Therapeutics

Bridge Therapeutics

Bridge Therapeutics are pursuing FDA approval of a patented drug combination for the treatment of chronic pain in opioid experienced patients.
Raised
$3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$3,000,000
Venture capital (Series A) - 2019
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Bridge Therapeutics makes some noise.